Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

After reporting a 15% sequential decline in Izervay sales for the opening quarter of this year, Astellas has reversed the ...

Astellas Pharma Inc. recently created a new role — that of chief research & development officer — and named Cambridge ...

View today's Astellas Pharma Inc. stock price and latest 4503 news and analysis. Create real-time notifications to follow any changes in the live stock price.

View the latest Astellas Pharma Inc. ADR (ALPMY) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Review quarterly and annual revenue, net income, and cash flow for Astellas Pharma Inc (ALPMF:PINX) stock through the last fiscal year.

Astellas Pharma has bought bioelectronic medical devices firm iota Biosciences in a deal worth up to $429m, building on a previous research partnership.

Astellas Pharma has agreed its largest-ever acquisition, buying US biotech Iveric Bio in a deal that continues to build its presence in the ophthalmology sector, The $40-per-share offer values ...

Get the detailed quarterly/annual income statement for Astellas Pharma Inc. (ALPMY). Find out the revenue, expenses and profit or loss over the last fiscal year.